Back to Authors

Dialino-Felix, Annalisa

A5107819332 | I1320553840

Mayo Clinic

Amgen (United States)

Citations 2

A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial

Neurology Open Access | April 25, 2025 | Volume: 1 | Issue: 2 | Pages: No page available

10.1212/wn9.0000000000000007 | PMID 40625668

The Urgent Need for Evidence Over Anecdote: Equipoise in the ExTINGUISH Clinical Trial in Anti-NMDAR Encephalitis (P7-8.016)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211728